The present disclosure describes the use of genetic variance information
for folate transport or metabolism genes or pyrimidine transport or
metabolism genes in the selection of effective methods of treatment of a
disease or condition. The variance information is indicative of the
expected response of a patient to a method of treatment. Methods of
determining relevant variance information and additional methods of using
such variance information are also described.
